Researchers may have identified a medication that can reduce lung damage in people suffering from COVID-19.
The antiviral drug EIDD-2801 has been effective in mice at preventing severe pneumonia caused by the new coronavirus.
According to a new study, pneumonia is the likely culprit of severe disease and death in those infected.
Health experts say that now the drug has finished animal testing, it will begin human clinical trials later this spring.
Available for all permitted uses under our |License Terms|.
, No release required Available for all permitted uses under our |License Terms|.
, Model released Available for all permitted uses under our |License Terms|.
, Model and property released
(Part 1 of 2) With millions of people out of work and losing their health insurance during the worst pandemic in a century, we..
China has approved early-stage human tests for two experimental vaccines to combat the coronavirus as it battles to contain..
The COVID-19 coronavirus, or SARS-CoV-2, targets human cells with ACE2 receptors, which are found in the respiratory system. The..
